Tregs in T cell vaccination: exploring the regulation of regulation

被引：57

作者：

Cohen, IR ^{[1
]}

Quintana, FJ ^{[1
]}

Mimran, A ^{[1
]}

机构：

[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2004年 / 114卷 / 09期

关键词：

D O I：

10.1172/JCI200422396

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

T cell vaccination (TCV) activates Tregs of 2 kinds: and-idiotypic (anti-id) and anti-ergotypic (anti-erg). These regulators furnish a useful view of the physiology of T cell regulation of the immune response. Anti-id Tregs recognize specific effector clones by their unique TCR CDR3 peptides; anti-id networks of CD4(+) and CD8(+) Tregs have been described in detail. Here we shall focus on anti-erg T regulators. Anti-erg T cells, unlike anti-id T cells, do not recognize the clonal identity of effector T cells; rather, anti-erg T cells recognize the state of activation of target effector T cells, irrespective of their TCR specificity. We consider several features of anti-erg T cells: their ontogeny, subset markers, and target ergotope molecules; mechanisms by which they regulate other T cells; mechanisms by which they get regulated; and therapeutic prospects for anti-erg upregulation and downregulation.

引用

页码：1227 / 1232

页数：6

共 40 条

[31] DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes [J].

Quintana, FJ ;

Carmi, P ;

Cohen, IR .

JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :6030-6035

[32] β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277):: a randomised, double-blind, phase II trial [J].

Raz, I ;

Elias, D ;

Avron, A ;

Tamir, M ;

Metzger, M ;

Cohen, IR .

LANCET, 2001, 358 (9295) :1749-1753

[33] STIMULATION OF HUMAN LYMPHOCYTES-T BY PHA-ACTIVATED AUTOLOGOUS LYMPHOCYTES-T - ANALYSIS OF THE ROLE OF IA-LIKE ANTIGENS WITH MONOCLONAL-ANTIBODIES [J].

RUSSO, C ;

INDIVERI, F ;

QUARANTA, V ;

MOLINARO, GA ;

PELLEGRINO, MA ;

FERRONE, S .

IMMUNOGENETICS, 1981, 12 (3-4) :267-274

[34] Regulatory T cells: Key controllers of immunologic self-tolerance [J].

Sakaguchi, S .

CELL, 2000, 101 (05) :455-458

[35]

Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885

[36] T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study [J].

Van der AA, A ;

Hellings, N ;

Medaer, R ;

Gelin, G ;

Palmers, Y ;

Raus, J ;

Stinissen, P .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 131 (01) :155-168

[37] IMMUNIZATION WITH A SYNTHETIC T-CELL RECEPTOR V-REGION PEPTIDE PROTECTS AGAINST EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS [J].

VANDENBARK, AA ;

HASHIM, G ;

OFFNER, H .

NATURE, 1989, 341 (6242) :541-544

[38] THE IL-2/IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 159-164, 1993) [J].

WALDMANN, TA .

IMMUNOLOGY TODAY, 1993, 14 (06) :264-270

[39] RETRACTED: T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors (Retracted Article) [J].

Zanin-Zhorov, A ;

Nussbaum, G ;

Franitza, S ;

Cohen, IR ;

Lider, O .

FASEB JOURNAL, 2003, 17 (09) :1567-+

[40]

Zhang Jingwu, 2002, Expert Rev Vaccines, V1, P285, DOI 10.1586/14760584.1.3.285

← 1 2 3 4 →